Multiple Myeloma Maintenance Strategies after Transplant or CAR T-cell Therapy
Presenter: Tara Gregory MD, Colorado Blood Cancer Institute@HCA Healthcare Sarah Cannon Cancer Network This workshop took place during the 2026 Celebrating a Second Chance at Life Survivorship Symposium.
▶︎
FAQs: Understanding High-Risk Multiple Myeloma: Beyond Genetics and Key Considerations
▶︎
The Present and Future of CAR T-cell Therapy
▶︎
Hope from Louisiana: Alan's Multiple Myeloma Story
▶︎
Graft-versus-Host Disease of the Skin and Fascia
▶︎
The CAR T Option
▶︎
Current Management of Vascular Graft Infections
▶︎
The Strain of Worry: Mental Health in Transplant Survivorship
▶︎
The Mind After Transplant and CAR T
▶︎
Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals
▶︎
Transplant and CAR T In Older Adults
▶︎
Introduction to Graft-versus-Host Disease (GVHD)
▶︎
Your Health After Allogeneic Transplant (Donor Stem Cells)
▶︎
FAQs: Immunotherapy for Multiple Myeloma: Exploring Options Through Your Disease Journey
▶︎
Protect Your Health and Thrive after a Transplant Using Donor Cells (Allogeneic)
▶︎
Treatment of Diffuse Large B-Cell Lymphoma (DLBCL): What you need to know
▶︎
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
▶︎
A Coag Conversation: 100 Years of Von Willebrand Disease & Upcoming Advances - Part 1
▶︎
Your Bones After Transplant and CAR T
▶︎
The Immune System After Transplant and CAR T
▶︎